Meitav Dash Investments LTD Mustang Bio, Inc. Transaction History

Meitav Dash Investments LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 06, 2021	SELL	$3.02 - $5.16 $88,788 - $151,704	-29,400 Closed	0 $0
Q4 2020 Feb 02, 2021	BUY	$2.66 - $4.18 $78,204 - $122,891	29,400 New	29,400 $111,000
Q3 2020 Nov 05, 2020	SELL	$3.01 - $3.88 $90,300 - $116,400	-30,000 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$2.33 - $4.6 $69,900 - $138,000	30,000 New	30,000 $95,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $23.1M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Meitav Dash Investments LTD, based on Form 13F filings with the SEC.

Stay updated on Meitav Dash Investments LTD with notifications on news.